Search Results

You searched for : Toxicology  

Xylazine: A Skin Rotting Drug

Xylazine, a new drug that is horrifying US citizens with its catastrophic effects, is also called the "Zombie Drug."...
Feb 23

Interesting Homeopathy Solutions for Chronic Diseases

Dr. Satish Gala gives important essential information on homeopathy for chronic diseases like neurological problems and cancer. He suggests homeopathy for palliative and preventive and ...
Jun 14

Community banking - A new innovation with LifeCell International Pvt Ltd

Ishaan Khana from LifeCell International Pvt Ltd gives insights into the booming community banking for cord blood cells. LifeCell International Pvt Ltd is India’s ...
Feb 10

Dr Kavita Tyagi provides her professional expertise on cardiovascular diseases

A must watch episode of Dr Kavita Tyagi giving insights about the heart system and various abnormalities of the heart other than the dangerous heart ...
Sep 25

Dr. Harsh Vardhan inaugurates multiple facilities at AIIMS Bhopal

Dream of Shri Atal Bihari Vajpayee ji being fulfilled with a network of AIIMS across the country for superior healthcare for all Citizens” said the ...
Mar 15

Experts confirm Chemicals in plastics damage babies' brains and must be banned immediately

Adverse effect of plastics on babies' brains...
Feb 22

PrEP Biopharm Limited announces Successful Completion of PrEP-001 Toxicology Study enabling Phase 2b Field Study of PrEP-001 Against All Respiratory Viruses

PrEP Biopharm Limited, intends to move forward with areal-world, field trial intended to validate the efficacy of its PrEP-001 against all circulating respiratory ...
Dec 17

Government Launches Mission COVID Suraksha to accelerate Indian COVID-19 Vaccine Development

Mission COVID Suraksha is the targeted effort to enable the development of indigenous, affordable and accessible vaccines for the country and will complement the National ...
Nov 30

Pierre Fabre and Y-Biologics are jointly researching new immunotherapies based on monoclonal antibodies

The two partners want to pool their expertise in order to identify and develop new monoclonal antibodies for cancer therapy...
Nov 24

Sai Life Sciences to significantly expand biology capabilities at its integrated R&D campus

Sai Life expands organizational transformation areas...
Oct 27

GigaGen Initiates large-scale manufacturing of it's COVID-19, drug GIGA-2050

GIGA-2050 is a new class of drug designed to provide passive immunity to COVID-19 patients or those at high risk....
Sep 16

Zydus starts human trial of plasmid DNA vaccine ZyCoV-D

Human dosing of the vaccine marks a key milestone since the launching of the accelerated vaccine development programme for COVID-19 in February 2020....
Jul 15

Aloe Vera - Amazing advantages you can't miss!

In the good 'ol days, the plant was known for being a "plant of everlasting status" and was introduced to Egyptian pharaohs as gifts....
Jun 24

Food Safety Day 2020: ‘Food safety: everyone’s business!’

World Food Day 2020 is devoted to each one of the individuals who have guaranteed that the COVID-19 emergency has not intruded on supply ...
Jun 07

Eurofins Announces Acquisition of Assets of Gomti Life Sciences

Eurofins, through Eurofins Advinus, acquires all assets of Gomti Life Sciences Private Limited through a Business Transfer Agreement....
Feb 07

Sai Life Sciences Commences Recruitment of 300+ Scientists

Sai Life Sciences, one of India's fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced that it has initiated the recruitment of 300+ scientists...
Jan 30

Porsolt Increases Its Drug Discovery Service Capabilities With the Recent Expansion of Its Research Facility

Porsolt SAS, a long established preclinical screening, efficacy, and safety CRO, has completed a significant expansion of its research facility, adding a further 5,500 ...
Sep 13

Aptorum Group Has Initiated IND-Enabling Studies For Its ALS-4 Small Molecule Candidate For The Treatment Of Infections Caused By Staphylococcus Aureus Including MRSA

Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces that ...
Sep 12

18 Matching result(s) found!

-Advertisements-